Literature DB >> 24941374

Dendritic cell editing by natural killer cells.

Guido Ferlazzo1, Lorenzo Moretta2.   

Abstract

Activated, mature, dendritic cells (DCs) are the main antigen-presenting cells for initiating adaptive immune responses, whereas immature DCs have been implicated in tolerance and induction of regulatory T cells. It is now well established that NK cells are able to discriminate between mature and immature DCs by killing the latter because of their low amount of surface human leukocyte antigen (HLA) class I molecules. Thus, NK cells are thought to play an important regulatory role by selectively editing DCs during the course of immune responses. NK-mediated killing of immature (but not mature) DCs results in selection of immunogenic DCs during the initiation of anti-cancer immune responses. In addition to the removal of inappropriate DCs, NK cells can also shape adaptive immune responses by promoting DC maturation and influencing the polarization of primary T-cell responses. DC-NK cell interactions should be carefully considered in DC-based cancer vaccine strategies. Optimal NK cell activation should be sought to enhance the magnitude and the quality of both innate and adaptive immune responses against tumors.

Entities:  

Mesh:

Year:  2014        PMID: 24941374     DOI: 10.1615/critrevoncog.2014010827

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  21 in total

1.  Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.

Authors:  Hansol Lee; Camelia Quek; Ines Silva; Annie Tasker; Marcel Batten; Helen Rizos; Su Yin Lim; Tuba Nur Gide; Ping Shang; Grace H Attrill; Jason Madore; Jarem Edwards; Matteo S Carlino; Alexander Guminski; Robyn P M Saw; John F Thompson; Peter M Ferguson; Umaimainthan Palendira; Alexander M Menzies; Georgina V Long; Richard A Scolyer; James S Wilmott
Journal:  Oncoimmunology       Date:  2018-10-31       Impact factor: 8.110

Review 2.  NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors.

Authors:  Nathan C Horton; Porunelloor A Mathew
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

3.  Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.

Authors:  Chandan Verma; Viriya Kaewkangsadan; Jennifer M Eremin; Gerard P Cowley; Mohammad Ilyas; Mohamed A El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2015-06-04       Impact factor: 5.531

Review 4.  NK cell function and receptor diversity in the context of HCV infection.

Authors:  Clair M Gardiner
Journal:  Front Microbiol       Date:  2015-09-30       Impact factor: 5.640

Review 5.  Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.

Authors:  Silvia Pesce; Lorenzo Moretta; Alessandro Moretta; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2016-10-07       Impact factor: 7.561

6.  Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation.

Authors:  Andrea Ziblat; Sol Y Nuñez; Ximena Lucía Raffo Iraolagoitia; Raúl German Spallanzani; Nicolás I Torres; Jessica M Sierra; Florencia Secchiari; Carolina I Domaica; Mercedes B Fuertes; Norberto W Zwirner
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

7.  The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands.

Authors:  Silvia Pesce; Fredrik B Thoren; Claudia Cantoni; Carola Prato; Lorenzo Moretta; Alessandro Moretta; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2017-04-28       Impact factor: 7.561

Review 8.  Regulation of Natural Killer Cell Function by STAT3.

Authors:  Nicholas A Cacalano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

Review 9.  Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.

Authors:  Inga Hochnadel; Uta Kossatz-Boehlert; Nils Jedicke; Henrike Lenzen; Michael P Manns; Tetyana Yevsa
Journal:  Hum Vaccin Immunother       Date:  2017-11-07       Impact factor: 3.452

10.  In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells.

Authors:  N E El-Ashmawy; E A El-Zamarany; M L Salem; H A El-Bahrawy; G M Al-Ashmawy
Journal:  J Genet Eng Biotechnol       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.